Actin-binding protein plastin 3 (PLS-3) levels are reduced in spinal muscular atrophy (SMA), and transgenic reintroduction of PLS-3 rescues functional defects in SMA [174, 178]. This evidence concerns the gene PLS3 and spinal muscular atrophy.